Latest EQL Pharma News & Updates
See the latest news and media coverage for EQL Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.
Swedish generic pharmaceuticals developer and marketer
eqlpharma.com- Headquarters
- Sweden
- Company type
- Public company
- Number of employees
- 10–60
Last updated
Latest news about EQL Pharma
In short: EQL Pharma reported record quarterly sales growth, secured key European product approvals, and transitioned its listing to Nasdaq Stockholm.
Company announcements
-
EQL Pharma reports year-end results for April 2025–March 2026
Sales increased 6% to 120.2 MSEK in Q4, but margins fell due to one-off costs and logistics issues. Forecast for 2026/27 is 15% growth.
-
EQL Pharma's CEO presents Q3 FY 2025/26 results
More information is available via link.
-
EQL Pharma reports record quarter with 29% sales growth
Sales rose to 118.9 MSEK and EBITDA to 24.9 MSEK. A new product was launched and two management members were recruited. Forecast for the full year is 15% growth.
-
EQL Pharma publishes half-year report April–September 2025
Sales increased 1% to 86.4 MSEK in Q2 due to delivery disruptions. EBITDA margin fell to 10%. Forecast for 2025/26: 15% growth and 20% EBITDA.
Media coverage
-
EQL Pharma AB: Year-end Report April 2025 - March 2026
During the quarter, sales rose to SEK 120.2 million, an increase of 6% from SEK 113.3 million in the previous year. Growth for next year...
-
Pharmaceutical company report plummets - CEO managed to sell millions before
The pharmaceutical company EQL Pharma plummets 37 percent on its report, where the operating profit decreased from 23 to 5.1 million kronor and...
-
EQL Pharma AB: Mellozzan (melatonin) has been approved in Italy
EQL's key product Mellozzan® has now received Marketing Authorization approval from the health authority in Italy (AIFA), where it will be provided to patients by...
-
EQL Pharma ABSK-FLR Loan 2025(26/28) Bond
The EQL Pharma AB-Bond has a maturity date of 1/24/2028 I18N_bonds#descriptiontext#couponpart#undefinedcoupon The EQL Pharma AB-Bond was issued on the 1/24/2025 with ...
Track EQL Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Trending companies
Discover what's making headlines across other trending companies.
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove
Bluecore